Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
Nov 17, 2021
19:53
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!
Motley Fool Money